콜드 릴리프 롤온 시장 - 세계 업계 분석, 규모, 점유율, 성장, 동향, 예측(2032년)

The global cold relief roll-on market is poised for remarkable growth, projected to reach USD 607.26 million in 2025 and expand to USD 1068.03 million by 2032, with a compound annual growth rate (CAGR) of 8.40%. This growth is fueled by rising consumer preferences for convenient, portable, and natural solutions to manage cold symptoms. The sector is characterized by innovation in formulations, with products offering targeted relief for conditions like nasal congestion, headaches, and muscle aches. As consumer awareness grows, the market is set to undergo significant transformation in the coming years.

Market Insights

Cold relief roll-ons are topical formulations infused with ingredients such as menthol, eucalyptus, and other herbal extracts, providing quick and localized relief. These products cater to the modern consumer's demand for effective, easy-to-use remedies that align with on-the-go lifestyles. The market is expected to witness robust expansion, driven by advancements in product innovation and increasing consumer interest in natural and holistic wellness solutions.

Key Market Drivers

• 1. Convenience and Portability: The ease of application and portable nature of roll-ons make them an attractive choice for busy consumers seeking hassle-free cold symptom management.
• 2. Natural and Alternative Remedies: The growing emphasis on natural, wellness-oriented products has propelled the development of roll-ons incorporating essential oils and botanical extracts.
• 3. Consumer Awareness: Increased awareness of early intervention and non-invasive solutions for cold symptoms supports the demand for these products.

Business Opportunities

• 1. Digital Marketing and E-Commerce Expansion: Leveraging digital marketing strategies and enhancing product visibility on e-commerce platforms offer substantial growth opportunities. Companies can utilize influencer partnerships, social media campaigns, and targeted online promotions to broaden market reach.
• 2. Innovative Formulations: Developing roll-ons that combine cold relief with additional benefits, such as stress relief or immune support, opens avenues for premium and specialized offerings.

Regional Analysis

• Europe: Dominates the market, supported by a proactive healthcare approach, robust regulatory standards, and consumer inclination toward accessible, effective remedies.
• South Asia & Pacific: Emerges as the fastest-growing region due to increasing health consciousness, urbanization, and a burgeoning middle-class population actively seeking convenient cold relief solutions.

Market Performance Projections

The cold relief roll-on market is projected to reach USD 607.26 million in 2025, expanding to USD 1068.03 million by 2032, with a compound annual growth rate (CAGR) of 8.40% during the forecast period.

Key Recent Developments

1. New Product Launches:

In August 2023, BabyOrgano, an Ayurvedic baby care and wellness D2C business, secured significant funding to expand its portfolio. This development is expected to impact Ayurvedic wellness products, including cold relief roll-ons. Vicks launched a roll-on inhaler containing a unique blend of menthol and camphor, providing a convenient solution for headache and cold relief. This product enhances market diversity and aligns with consumer preferences for on-the-go remedies.

Competitive Intelligence and Strategy

Key players in the market include GlaxoSmithKline Plc., Abbott Laboratories, Procter and Gamble, and Viatris Inc., among others. To maintain a competitive edge, companies are focusing on:

• Regulatory Compliance: Ensuring adherence to stringent manufacturing and labeling standards.
• Product Innovation: Introducing unique formulations targeting broader health concerns.
• Strategic Partnerships: Collaborating with healthcare professionals and influencers to enhance product credibility and visibility.
• Digital Outreach: Optimizing e-commerce platforms and engaging directly with tech-savvy consumers.

Key Players Profiled

• GlaxoSmithKline Plc.
• Abbott Laboratories
• Procter and Gamble
• Viatris Inc.
• Johnson & Johnson
• Cipla Ltd.
• Innovus Pharmaceuticals, Inc.
• Novartis AG (Sandoz International GmbH)
• Mylan N.V.
• Sumitomo Dainippon Pharma (Sunovion Pharmaceuticals Inc.)

Market Segmentation

1. By Application:

Cold/Cough Nasal Allergies Nasal Congestion Others

2. By Distribution Channel:

Retail Pharmacies Hospital Pharmacies E-Commerce Hypermarket/Supermarket

3. By Region:

North America Europe East Asia South Asia & Oceania Latin America Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Cold Relief Roll on Market Snapshot
• 1.2. Future Projections
• 1.3. Key Market Trends
• 1.4. Regional Snapshot, by Value and Volume, 2025
• 1.5. Analyst Recommendations

2. Market Overview

• 2.1. Market Definitions and Segmentations
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Market Opportunities
• 2.3. Value Chain Analysis
• 2.4. Porter's Five Forces Analysis
• 2.5. COVID-19 Impact Analysis
  • 2.5.1. Supply
  • 2.5.2. Demand
• 2.6. PESTLE Analysis

3. Price Analysis, 2019 - 2023

• 3.1. Global Average Price Analysis, by Application, US$ Per Unit, 2019 - 2023
• 3.2. Prominent Factor Affecting Cold Relief Roll on Prices
• 3.3. Global Average Price Analysis, by Region, US$ Per Unit

4. Global Cold Relief Roll on Market Outlook, 2019 - 2032

• 4.1. Global Cold Relief Roll on Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2019 - 2032
  • 4.1.1. Key Highlights
    • 4.1.1.1. Cold/Cough
    • 4.1.1.2. Nasal Allergies
    • 4.1.1.3. Nasal Congestion
    • 4.1.1.4. Others
• 4.2. Global Cold Relief Roll on Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
  • 4.2.1. Key Highlights
    • 4.2.1.1. Retail Pharmacies
    • 4.2.1.2. Hospital Pharmacies
    • 4.2.1.3. E-Commerce
    • 4.2.1.4. Hypermarket/Supermarket
• 4.3. Global Cold Relief Roll on Market Outlook, by Region, Value (US$ Mn) and Volume (Units), 2019 - 2032
  • 4.3.1. Key Highlights
    • 4.3.1.1. North America
    • 4.3.1.2. Europe
    • 4.3.1.3. Asia Pacific
    • 4.3.1.4. Latin America
    • 4.3.1.5. Middle East & Africa

5. North America Cold Relief Roll on Market Outlook, 2019 - 2032

• 5.1. North America Cold Relief Roll on Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2019 - 2032
  • 5.1.1. Key Highlights
    • 5.1.1.1. Cold/Cough
    • 5.1.1.2. Nasal Allergies
    • 5.1.1.3. Nasal Congestion
    • 5.1.1.4. Others
• 5.2. North America Cold Relief Roll on Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
  • 5.2.1. Key Highlights
    • 5.2.1.1. Retail Pharmacies
    • 5.2.1.2. Hospital Pharmacies
    • 5.2.1.3. E-Commerce
    • 5.2.1.4. Hypermarket/Supermarket
  • 5.2.2. BPS Analysis/Market Attractiveness Analysis
• 5.3. North America Cold Relief Roll on Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2019 - 2032
  • 5.3.1. Key Highlights
    • 5.3.1.1. Cold Relief Roll on Market by Application, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 5.3.1.2. Cold Relief Roll on Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 5.3.1.3. Canada Cold Relief Roll on Market by Application, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 5.3.1.4. Canada Cold Relief Roll on Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
  • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Europe Cold Relief Roll on Market Outlook, 2019 - 2032

• 6.1. Europe Cold Relief Roll on Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2019 - 2032
  • 6.1.1. Key Highlights
    • 6.1.1.1. Cold/Cough
    • 6.1.1.2. Nasal Allergies
    • 6.1.1.3. Nasal Congestion
    • 6.1.1.4. Others
• 6.2. Europe Cold Relief Roll on Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
  • 6.2.1. Key Highlights
    • 6.2.1.1. Retail Pharmacies
    • 6.2.1.2. Hospital Pharmacies
    • 6.2.1.3. E-Commerce
    • 6.2.1.4. Hypermarket/Supermarket
  • 6.2.2. Attractiveness Analysis
• 6.3. Europe Cold Relief Roll on Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2019 - 2032
  • 6.3.1. Key Highlights
    • 6.3.1.1. Germany Cold Relief Roll on Market by Application, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 6.3.1.2. Germany Cold Relief Roll on Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 6.3.1.3. U.K. Cold Relief Roll on Market by Application, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 6.3.1.4. U.K. Cold Relief Roll on Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 6.3.1.5. France Cold Relief Roll on Market by Application, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 6.3.1.6. France Cold Relief Roll on Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 6.3.1.7. Italy Cold Relief Roll on Market by Application, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 6.3.1.8. Italy Cold Relief Roll on Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 6.3.1.9. Turkey Cold Relief Roll on Market by Application, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 6.3.1.10. Turkey Cold Relief Roll on Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 6.3.1.11. Russia Cold Relief Roll on Market by Application, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 6.3.1.12. Russia Cold Relief Roll on Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 6.3.1.13. Rest of Europe Cold Relief Roll on Market by Application, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 6.3.1.14. Rest of Europe Cold Relief Roll on Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
  • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Asia Pacific Cold Relief Roll on Market Outlook, 2019 - 2032

• 7.1. Asia Pacific Cold Relief Roll on Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2019 - 2032
  • 7.1.1. Key Highlights
    • 7.1.1.1. Cold/Cough
    • 7.1.1.2. Nasal Allergies
    • 7.1.1.3. Nasal Congestion
    • 7.1.1.4. Others
• 7.2. Asia Pacific Cold Relief Roll on Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
  • 7.2.1. Key Highlights
    • 7.2.1.1. Retail Pharmacies
    • 7.2.1.2. Hospital Pharmacies
    • 7.2.1.3. E-Commerce
    • 7.2.1.4. Hypermarket/Supermarket
  • 7.2.2. BPS Analysis/Market Attractiveness Analysis
• 7.3. Asia Pacific Cold Relief Roll on Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2019 - 2032
  • 7.3.1. Key Highlights
    • 7.3.1.1. China Cold Relief Roll on Market by Application, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 7.3.1.2. China Cold Relief Roll on Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 7.3.1.3. Japan Cold Relief Roll on Market by Application, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 7.3.1.4. Japan Cold Relief Roll on Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 7.3.1.5. South Korea Cold Relief Roll on Market by Application, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 7.3.1.6. South Korea Cold Relief Roll on Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 7.3.1.7. India Cold Relief Roll on Market by Application, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 7.3.1.8. India Cold Relief Roll on Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 7.3.1.9. Southeast Asia Cold Relief Roll on Market by Application, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 7.3.1.10. Southeast Asia Cold Relief Roll on Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 7.3.1.11. Rest of Asia Pacific Cold Relief Roll on Market by Application, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 7.3.1.12. Rest of Asia Pacific Cold Relief Roll on Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
  • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Latin America Cold Relief Roll on Market Outlook, 2019 - 2032

• 8.1. Latin America Cold Relief Roll on Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2019 - 2032
  • 8.1.1. Key Highlights
    • 8.1.1.1. Cold/Cough
    • 8.1.1.2. Nasal Allergies
    • 8.1.1.3. Nasal Congestion
    • 8.1.1.4. Others
• 8.2. Latin America Cold Relief Roll on Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
  • 8.2.1. Key Highlights
    • 8.2.1.1. Retail Pharmacies
    • 8.2.1.2. Hospital Pharmacies
    • 8.2.1.3. E-Commerce
    • 8.2.1.4. Hypermarket/Supermarket
  • 8.2.2. BPS Analysis/Market Attractiveness Analysis
• 8.3. Latin America Cold Relief Roll on Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2019 - 2032
  • 8.3.1. Key Highlights
    • 8.3.1.1. Brazil Cold Relief Roll on Market by Application, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 8.3.1.2. Brazil Cold Relief Roll on Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 8.3.1.3. Mexico Cold Relief Roll on Market by Application, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 8.3.1.4. Mexico Cold Relief Roll on Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 8.3.1.5. Argentina Cold Relief Roll on Market by Application, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 8.3.1.6. Argentina Cold Relief Roll on Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 8.3.1.7. Rest of Latin America Cold Relief Roll on Market by Application, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 8.3.1.8. Rest of Latin America Cold Relief Roll on Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
  • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Middle East & Africa Cold Relief Roll on Market Outlook, 2019 - 2032

• 9.1. Middle East & Africa Cold Relief Roll on Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2019 - 2032
  • 9.1.1. Key Highlights
    • 9.1.1.1. Cold/Cough
    • 9.1.1.2. Nasal Allergies
    • 9.1.1.3. Nasal Congestion
    • 9.1.1.4. Others
• 9.2. Middle East & Africa Cold Relief Roll on Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
  • 9.2.1. Key Highlights
    • 9.2.1.1. Retail Pharmacies
    • 9.2.1.2. Hospital Pharmacies
    • 9.2.1.3. E-Commerce
    • 9.2.1.4. Hypermarket/Supermarket
  • 9.2.2. BPS Analysis/Market Attractiveness Analysis
• 9.3. Middle East & Africa Cold Relief Roll on Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2019 - 2032
  • 9.3.1. Key Highlights
    • 9.3.1.1. GCC Cold Relief Roll on Market by Application, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 9.3.1.2. GCC Cold Relief Roll on Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 9.3.1.3. South Africa Cold Relief Roll on Market by Application, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 9.3.1.4. South Africa Cold Relief Roll on Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 9.3.1.5. Egypt Cold Relief Roll on Market by Application, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 9.3.1.6. Egypt Cold Relief Roll on Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 9.3.1.7. Nigeria Cold Relief Roll on Market by Application, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 9.3.1.8. Nigeria Cold Relief Roll on Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 9.3.1.9. Rest of Middle East & Africa Cold Relief Roll on Market by Application, Value (US$ Mn) and Volume (Units), 2019 - 2032
    • 9.3.1.10. Rest of Middle East & Africa Cold Relief Roll on Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019 - 2032
  • 9.3.2. BPS Analysis/Market Attractiveness Analysis

10. Competitive Landscape

• 10.1. Company Market Share Analysis, 2025
• 10.2. Competitive Dashboard
• 10.3. Company Profiles
  • 10.3.1. Glaxosmithkline Plc.
    • 10.3.1.1. Company Overview
    • 10.3.1.2. Product Portfolio
    • 10.3.1.3. Financial Overview
    • 10.3.1.4. Business Strategies and Development
  • 10.3.2. Abbott Laboratories
    • 10.3.2.1. Company Overview
    • 10.3.2.2. Product Portfolio
    • 10.3.2.3. Financial Overview
    • 10.3.2.4. Business Strategies and Development
  • 10.3.3. Procter and Gamble
    • 10.3.3.1. Company Overview
    • 10.3.3.2. Product Portfolio
    • 10.3.3.3. Financial Overview
    • 10.3.3.4. Business Strategies and Development
  • 10.3.4. Viatris Inc.
    • 10.3.4.1. Company Overview
    • 10.3.4.2. Product Portfolio
    • 10.3.4.3. Financial Overview
    • 10.3.4.4. Business Strategies and Development
  • 10.3.5. Johnson & Johnson
    • 10.3.5.1. Company Overview
    • 10.3.5.2. Product Portfolio
    • 10.3.5.3. Financial Overview
    • 10.3.5.4. Business Strategies and Development
  • 10.3.6. Cipla Ltd.
    • 10.3.6.1. Company Overview
    • 10.3.6.2. Product Portfolio
    • 10.3.6.3. Financial Overview
    • 10.3.6.4. Business Strategies and Development

11. Appendix

• 11.1. Research Methodology
• 11.2. Report Assumptions
• 11.3. Acronyms and Abbreviations